Karen Brunke

Karen Brunke

Director/Board Member at CYTODYN INC.

Net worth: - $ as of 2026-09-29

74 year
Health Technology
Consumer Services

Profile

Dr. Karen J.
Brunke
is a Chief Executive Officer at Magdalena Biosciences, Inc. and an Independent Director at CytoDyn, Inc. She is on the Board of Directors at CytoDyn, Inc. Dr. Brunke was previously employed as an Executive VP-Corporate & Business Development by Jaguar Health, Inc., a Chief Executive Officer by Cardeus Pharmaceuticals, Inc., and a Chief Operating Officer by Anexus Pharmaceuticals.
She received her undergraduate degree from the University of Pennsylvania and a doctorate degree from the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-19 0 ( -.--% ) - $ 2026-09-29

Karen Brunke active positions

CompaniesPositionStart
CYTODYN INC. Director/Board Member 2022-03-31
Chief Executive Officer 2022-12-31

Former positions of Karen Brunke

CompaniesPositionEnd
JAGUAR HEALTH, INC. Corporate Officer/Principal 2025-12-31
Cardeus Pharmaceuticals, Inc.
Chief Executive Officer 2014-02-28
See the detail of Karen Brunke's experience

Education of Karen Brunke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

22

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Cardeus Pharmaceuticals, Inc.

Health Technology

Health Technology